Patents by Inventor Tonya L. Martin

Tonya L. Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using alpha-methylglucoside (AMG) as an indicator for glucose absorption and excretion
    Patent number: 8147801
    Abstract: Presented here are methods using alpha-methylglucoside (AMG) in vivo as an indicator for glucose absorption from the gastrointestinal (GI) system or glucose excretion in the urine after oral administration of AMG. The methods find use in, for example, but not limited to, determining the effect of a sodium-dependent glucose transporter (SGLT) inhibitor in an animal, comparing the differences in the effects of a first and second SGLT inhibitor in an animal, and diagnosing a disease associated with glucose absorption from the gastrointestinal (GI) system or glucose excretion from the kidney in an animal.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: April 3, 2012
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Keith T. Demarest, James M. Lenhard, Gregory C. Leo, Yin Liang, Tonya L. Martin
  • USE OF ALPHA-METHYLGLUCOSIDE (AMG) AS AN INDICATOR FOR GLUCOSE ABSORPTION AND EXCRETION
    Publication number: 20110065200
    Abstract: Presented here are methods using alpha-methylglucoside (AMG) in vivo as an indicator for glucose absorption from the gastrointestinal (GI) system or glucose excretion in the urine after oral administration of AMG. The methods find use in, for example, but not limited to, determining the effect of a sodium-dependent glucose transporter (SGLT) inhibitor in an animal, comparing the differences in the effects of a first and second SGLT inhibitor in an animal, and diagnosing a disease associated with glucose absorption from the gastrointestinal (GI) system or glucose excretion from the kidney in an animal.
    Type: Application
    Filed: September 14, 2010
    Publication date: March 17, 2011
    Applicant: Janssen Pharmaceutica, N.V.
    Inventors: Keith T. Demarest, James M. Lenhard, Gregory C. Leo, Yin Liang, Tonya L. Martin